Let's shape this report
around your question
Tell us what you'd like added, extended, or refined. You'll receive a scoping note and cost estimate within two business days.
REPORT IN CONTEXT
Gene Therapy in CNS Disorder Market: AAV Vector Platforms, Rare Disease Pipelines, and Regulatory Pathway Innovation
PublishedSep 2026
Pages337
Horizon2026-2036
LEAD ANYLYST
AB
Alice BallengerHead of Research · Healthcare

